{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:23:55Z","timestamp":1777310635422,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grants-in-Aid for Scientific Research on Innovative Areas from Ministry of Education, Culture, Sports, Science and Technology, Japan","award":["26119531"],"award-info":[{"award-number":["26119531"]}]},{"name":"Grants-in-Aid for Scientific Research on Innovative Areas from Ministry of Education, Culture, Sports, Science and Technology, Japan","award":["26118518"],"award-info":[{"award-number":["26118518"]}]},{"name":"Health Labour Sciences Research Grant from Ministry of Health, Labour and Welfare, Japan","award":["H25-Seishin-Jituyouka(Seishin)-Ippan-001"],"award-info":[{"award-number":["H25-Seishin-Jituyouka(Seishin)-Ippan-001"]}]},{"name":"the Brain Mapping by Integrated Neurotechnologies for Disease Studies from Japan Agency for Medical Research and Development"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00259-016-3332-6","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T19:52:11Z","timestamp":1456170731000},"page":"1653-1663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["[11C]TASP457, a novel PET ligand for histamine H3 receptors in human brain"],"prefix":"10.1007","volume":"43","author":[{"given":"Yasuyuki","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Ichise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Moriguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitoshi","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Suhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,23]]},"reference":[{"key":"3332_CR1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","volume":"302","author":"JM Arrang","year":"1983","unstructured":"Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature. 1983;302:832\u20137.","journal-title":"Nature"},{"key":"3332_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrn1034","volume":"4","author":"H Haas","year":"2003","unstructured":"Haas H, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci. 2003;4:121\u201330.","journal-title":"Nat Rev Neurosci"},{"key":"3332_CR3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1460-9568.1999.00453.x","volume":"11","author":"RE Goodchild","year":"1999","unstructured":"Goodchild RE, Court JA, Hobson I, Piggott MA, Perry RH, Ince P, et al. Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington\u2019s and Parkinson\u2019s disease cases. Eur J Neurosci. 1999;11:449\u201356.","journal-title":"Eur J Neurosci"},{"key":"3332_CR4","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjp.2008.147","volume":"154","author":"TA Esbenshade","year":"2008","unstructured":"Esbenshade TA, Browman KE, Bitner RS, Strakhova M, Cowart MD, Brioni JD. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol. 2008;154:1166\u201381.","journal-title":"Br J Pharmacol"},{"key":"3332_CR5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2967\/jnumed.109.071753","volume":"51","author":"S Ashworth","year":"2010","unstructured":"Ashworth S, Rabiner EA, Gunn RN, Plisson C, Wilson AA, Comley RA, et al. Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET. J Nucl Med. 2010;51:1021\u20139.","journal-title":"J Nucl Med"},{"key":"3332_CR6","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/bph.12505","volume":"171","author":"S Ashworth","year":"2014","unstructured":"Ashworth S, Berges A, Rabiner EA, Wilson AA, Comley RA, Lai RYK, et al. Unexpectedly high affinity of a novel histamine H3 receptor antagonist, GSK239512, in vivo in human brain, determined using PET. Br J Pharmacol. 2014;171:1241\u20139.","journal-title":"Br J Pharmacol"},{"key":"3332_CR7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1017\/S1461145712001411","volume":"16","author":"A Jucaite","year":"2013","unstructured":"Jucaite A, Takano A, Bostr\u00f6m E, Jostell K-G, Stenkrona P, Halldin C, et al. AZD5213: a novel histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy, a PET study in human subjects. Int J Neuropsychopharmacol. 2013;16:1231\u20139.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3332_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2967\/jnumed.113.122515","volume":"55","author":"KJ Laere Van","year":"2014","unstructured":"Van Laere KJ, Sanabria-Boh\u00f3rquez SM, Mozley DP, Burns DH, Hamill TG, Van Hecken A, et al. 11C-MK-8278 PET as a tool for pharmacodynamic brain occupancy of histamine 3 receptor inverse agonists. J Nucl Med. 2014;55:65\u201372.","journal-title":"J Nucl Med"},{"key":"3332_CR9","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/jpet.107.120311","volume":"321","author":"AD Medhurst","year":"2007","unstructured":"Medhurst AD, Atkins AR, Beresford IJ, Brackenborough K, Briggs MA, Calver AR, et al. GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer\u2019s disease brain and improves cognitive performance in preclinical models. J Pharmacol Exp Ther. 2007;321:1032\u201345.","journal-title":"J Pharmacol Exp Ther"},{"key":"3332_CR10","doi-asserted-by":"publisher","unstructured":"Koga K, Maeda J, Tokunaga M, Hanyu M, Kawamura K, Ohmichi M, et al. Development of TASP0410457 (TASP457), a novel dihydroquinolinone derivative as a PET radioligand for central histamine H3 receptors. EJNMMI Res. 2016. doi: 10.1186\/s13550-016-0170-2 .","DOI":"10.1186\/s13550-016-0170-2"},{"key":"3332_CR11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2967\/jnumed.109.063701","volume":"51","author":"M Wardak","year":"2010","unstructured":"Wardak M, Wong KP, Shao W, Dahlbom M, Kepe V, Satyamurthy N, et al. Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans. J Nucl Med. 2010;51:210\u20138.","journal-title":"J Nucl Med"},{"key":"3332_CR12","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3332_CR13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716\u201323.","journal-title":"IEEE Trans Automat Contr"},{"key":"3332_CR14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1098-2396(19991215)34:4<290::AID-SYN5>3.0.CO;2-B","volume":"34","author":"M Fujita","year":"1999","unstructured":"Fujita M, Seibyl JP, Verhoeff NP, Ichise M, Baldwin RM, Zoghbi SS, et al. Kinetic and equilibrium analyses of [123I]epidepride binding to striatal and extrastriatal dopamine D2 receptors. Synapse. 1999;34:290\u2013304.","journal-title":"Synapse"},{"key":"3332_CR15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/jcbfm.1986.30","volume":"6","author":"RA Hawkins","year":"1986","unstructured":"Hawkins RA, Phelps ME, Huang SC. Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood\u2013brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET. J Cereb Blood Flow Metab. 1986;6:170\u201383.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3332_CR16","first-page":"347","volume-title":"Positron emission tomography and autoradiography: principle applications for the brain and the heart","author":"RE Carson","year":"1986","unstructured":"Carson RE. Parameters estimation in positron emission tomography. In: Phelps ME, Mazziotta JC, Schelbert H, editors. Positron emission tomography and autoradiography: principle applications for the brain and the heart. New York: Raven Press; 1986. p. 347\u201390."},{"key":"3332_CR17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","volume":"10","author":"J Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(\u2212)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3332_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00004647-200103000-00014","volume":"21","author":"J Logan","year":"2001","unstructured":"Logan J, Fowler JS, Volkow ND, Ding Y-S, Wang G-J, Alexoff DL. A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab. 2001;21:307\u201320.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3332_CR19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.WCB.0000038000.34930.4E","volume":"22","author":"M Ichise","year":"2002","unstructured":"Ichise M, Toyama H, Innis RB, Carson RE. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab. 2002;22:1271\u201381.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3332_CR20","first-page":"1902","volume":"40","author":"M Ichise","year":"1999","unstructured":"Ichise M, Fujita M, Seibyl JP, Verhoeff NP, Baldwin RM, Zoghbi SS, et al. Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECT. J Nucl Med. 1999;40:1902\u201312.","journal-title":"J Nucl Med"},{"key":"3332_CR21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nucmedbio.2013.08.008","volume":"41","author":"Y Kimura","year":"2014","unstructured":"Kimura Y, Ito H, Shiraishi T, Fujiwara H, Kodaka F, Takano H, et al. Biodistribution and radiation dosimetry in humans of [11C]FLB 457, a positron emission tomography ligand for the extrastriatal dopamine D2 receptor. Nucl Med Biol. 2014;41:102\u20135.","journal-title":"Nucl Med Biol"},{"key":"3332_CR22","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023\u20137.","journal-title":"J Nucl Med"},{"key":"3332_CR23","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.neuroimage.2008.03.004","volume":"41","author":"G Terry","year":"2008","unstructured":"Terry G, Liow J-S, Chernet E, Zoghbi SS, Phebus L, Felder CC, et al. Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents. Neuroimage. 2008;41:690\u20138.","journal-title":"Neuroimage"},{"key":"3332_CR24","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/syn.20689","volume":"63","author":"TG Hamill","year":"2009","unstructured":"Hamill TG, Sato N, Jitsuoka M, Tokita S, Sanabria S, Eng W, et al. Inverse agonist histamine H3 receptor PET tracers labelled with carbon-11 or fluorine-18. Synapse. 2009;63:1122\u201332.","journal-title":"Synapse"},{"key":"3332_CR25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00259-011-2005-8","volume":"39","author":"P Zanotti-Fregonara","year":"2012","unstructured":"Zanotti-Fregonara P, Innis RB. Suggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies. Eur J Nucl Med Mol Imaging. 2012;39:544\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3332-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-016-3332-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3332-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:06:31Z","timestamp":1558699591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-016-3332-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["3332"],"URL":"https:\/\/doi.org\/10.1007\/s00259-016-3332-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]}}}